Valsartan Recalled In United States Due To Carcinogenic Ingredient
SILVER SPRING, Md. — Three generic drug manufacturers have voluntarily recalled the high blood pressure and heart failure drug valsartan after discovering that they contain a N-nitrosodimethylamine (NDMA), which is classified...To view the full article, register now.
Already a subscriber? Click here to view full article